Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FOBs: Industry Begins To Plot Course Along Pathway As It Awaits FDA Policy

Jul 05 2010

• By The Pink Sheet

Related Content

Big Pharma Tries Out New Class On The Diabetes Block: SGLT-2

Jul 01 2009

Teva, Eyeing Follow-Ons For Most Biologics, Starts With Amgen's Neupogen

Dec 07 2009

Beyond Gleevec: What's Next For Novartis Oncology?

Dec 14 2009

Merck Buys Contract Manufacturing Org Avecia To Advance Biologics Strategy

Dec 17 2009

Forest Acquires U.S. Rights To Nycomed's Oral COPD Drug Daxas

Aug 10 2009

Did Vyvanse Internet Ads Draw A Subpoena? Shire ADHD Promotions Get Government's Attention

Oct 30 2009

CAP Drugs Must Meet Stricter Noninferiority Criteria Under Draft FDA Guidance

Jun 08 2009

Onyx Sees Blockbuster In Oncology Drug Carflizomib, Buys Proteolix To Get It

Oct 12 2009

Both AstraZeneca/Bristol Diabetes Drugs Should Meet FDA Guidance

Jan 30 2009

Nycomed Reviewing Bids For U.S. Partners For Daxas

Mar 25 2009

Ibuprofen Topicals Draw Unapproved New Drug Warnings

Aug 24 2009

Merck/Schering: The Next Wave Of Consolidation

Mar 16 2009

GSK Stands By Avandia: Seeks Label Change, Asks Docs To Give It Another Try

Jun 22 2009

Daxas REMS May Be Key To Approval After "Complete Response" Letter

May 18 2010

FDA Creates Biosimilars Overseer In Drug Office; Internal Panel To Advise Application Reviewers

May 20 2010

Roche's Actemra Approved For RA After Year's Delay - To Craft A REMS?

Jan 18 2010

Statistics Bedeviled Cymbalta Fibromyalgia NDA, Derail Chronic Pain Claim

Dec 08 2008

Martek Expects Growth With Restructuring Plan, Including Layoffs

Oct 30 2006

CDER Offices Go Public With “Fundamental Disagreement” Over Avandia

Aug 06 2007

Mylan Must Give FTC 30-Day Notice Before Any Exclusive Bulk Agreement

Dec 04 2000

Under New CEO, Glaxo Will Leverage OTCs In Emerging Markets

May 05 2008

FDA’s Advertising Enforcement Turns Its Focus To YouTube, ADHD Drugs

Oct 06 2008

Antibiotic Development: FDA Says New Guidances Will Help, But Industry Questions Statistical Focus

Jun 28 2010

Senate Democrats Have "No Doubt" That Berwick Will Be Confirmed As CMS Administrator, Staffer Says

Jun 22 2010

South Korean Pharmas Clamber For Partnerships To Survive Rapidly Changing Environment

Jun 15 2010

Impromptu Objections Filed With SEC Could Threaten Charles River's Proposed Merger With China's Leading CRO

Jun 11 2010

Korean Government Announces Joint Fund To Beef Up Local Pharma Industry

Feb 10 2010

Forest's Daxas Is Safe And Is Effective, But Not Both, Panel Finds

Apr 07 2010

Will Berwick Transform CMS Into Center For Health Quality?

Apr 26 2010

Merck Puffs Up Respiratory Portfolio With EU Rights To Nycomed's Daxas

Apr 26 2010

"Bad CME" Program May Be Developed By FDA

Jun 25 2010

Sales & Earnings In Brief

Feb 15 2010

UK's NICE Says No To Two CML Drugs; Invites Cost-Sharing Schemes

Feb 15 2010

LG Life Science Tops R&D Investment List of Korea-Listed Pharmas

Oct 08 2009

Short Attention Span? Shire Cited Again For Out-Of-Bounds ADHD Promotion

Jul 01 2010

GSK Settles Hundreds Of Avandia Suits Before FDA Advisory Cmte. Meeting

May 17 2010

Merck's Backbone Is Cardiovascular, Infectious Disease After Pipeline Integration

Mar 01 2010

On The Cusp Of Biosimilars: Reform Ushers In Next Generic Drug Era

Mar 29 2010

Merck’s Ambitious Plans For Follow-On Biologics

Dec 15 2008

New Products In Brief

Jan 25 2010

Biosimilars Pathway Has Blind Spots As FDA And Firms Begin Roadwork

May 03 2010

Sandoz Will Steer Clear Of U.S. Biosimilars Pathway, Use Other Applications

May 03 2010

Merck Likes Biosimilars, But Not ESAs

May 11 2010

Avandia Committee Review: FDA Puts Five Options On Table For Advisory Panels

Jul 09 2010

FDA Drug Review Staff Split On Avandia's CV Safety In RECORD Study

Jul 09 2010

IoM Report On Postmarketing Study Ethics Could Drive Broad Overhaul Of Informed Consent

Jul 09 2010

Millennium Prospers Under Takeda--But Will Takeda Get Full Value?

Jun 01 2009

Orphan Drug Reviews: Industry Wants FDA To Move Out Of Its Comfort Zone

Jul 05 2010

Merck Prepares To Test Drive Biosimilar Pathway In The U.S.

Jul 05 2010

Corporate Biotech Incubators

Dec 01 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window